Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection

Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection

Reactivation of latent cytomegalovirus (CMV) endangers the therapeutic success of hematopoietic cell transplantation (HCT) in tumor patients due to cytopathogenic virus spread that leads to organ manifestations of CMV disease, to interstitial pneumonia in particular. In cases of virus variants that...

Full description

Bibliographic Details
Main Authors:	Kerstin M. Gergely, Jürgen Podlech, Sara Becker, Kirsten Freitag, Steffi Krauter, Nicole Büscher, Rafaela Holtappels, Bodo Plachter, Matthias J. Reddehase, Niels A. W. Lemmermann
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Immunology
Subjects:	adoptive cell transfer antiviral protection HCMV dense bodies subviral particles T cell receptor transgenic cells T cell priming
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.694588/full

Similar Items

Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
by: Lauren Stern, et al.
Published: (2019-05-01)

Differential outcome of neurological HCMV infection in two hematopoietic stem cell transplant recipients
by: Colombo Anna, et al.
Published: (2012-10-01)

Consequence of Histoincompatibility beyond GvH-Reaction in Cytomegalovirus Disease Associated with Allogeneic Hematopoietic Cell Transplantation: Change of Paradigm
by: Matthias J. Reddehase, et al.
Published: (2021-08-01)

Human Cytomegalovirus Cell Tropism and Host Cell Receptors
by: Giuseppe Gerna, et al.
Published: (2019-07-01)

The Molecular Tweezer CLR01 Inhibits Antibody-Resistant Cell-to-Cell Spread of Human Cytomegalovirus
by: Sina Brenner, et al.
Published: (2021-08-01)

Comparison of HCMV DNA load and antigenemia results in hematopoietic transplant recipients based on GVHD grade
by: Pajand O, et al.
Published: (2007-05-01)

The Human Cytomegalovirus, from Oncomodulation to Oncogenesis
by: Georges Herbein
Published: (2018-08-01)

Human Cytomegalovirus Infection Alters PC3 Prostate Carcinoma Cell Adhesion to Endothelial Cells, Extracellular Matrix
by: Roman A. Blaheta, et al.
Published: (2006-10-01)

Human Cytomegalovirus-Induced Degradation of CYTIP Modulates Dendritic Cell Adhesion and Migration
by: Christiane S. Heilingloh, et al.
Published: (2017-04-01)

Revisiting CD8 T-cell ‘Memory Inflation’: New Insights with Implications for Cytomegaloviruses as Vaccine Vectors
by: Rafaela Holtappels, et al.
Published: (2020-07-01)

Mutual Interference between Cytomegalovirus and Reconstitution of Protective Immunity after Hematopoietic Cell Transplantation
by: Matthias J. Reddehase
Published: (2016-08-01)

Identification of UL69 Gene and Protein in Cytomegalovirus-Transformed Human Mammary Epithelial Cells
by: Sandy Haidar Ahmad, et al.
Published: (2021-04-01)

Insufficient Antigen Presentation Due to Viral Immune Evasion Explains Lethal Cytomegalovirus Organ Disease After Allogeneic Hematopoietic Cell Transplantation
by: Rafaela Holtappels, et al.
Published: (2020-04-01)

Characterization Of The Interaction Between Subviral Particles Of Hepatitis B Virus And Dendritic Cells – In Vitro Study
by: Farag MMS, et al.
Published: (2019-10-01)

CD147 Promotes Entry of Pentamer-Expressing Human Cytomegalovirus into Epithelial and Endothelial Cells
by: Adam L. Vanarsdall, et al.
Published: (2018-05-01)

The Role of RhoA, RhoB and RhoC GTPases in Cell Morphology, Proliferation and Migration in Human Cytomegalovirus (HCMV) Infected Glioblastoma Cells
by: Melpomeni Tseliou, et al.
Published: (2016-01-01)

Antiviral Drug- and Multidrug Resistance in Cytomegalovirus Infected SCT Patients
by: Katharina Göhring, et al.
Published: (2015-01-01)

The DNA Damage Response Induced by Infection with Human Cytomegalovirus and Other Viruses
by: Xiaofei E, et al.
Published: (2014-05-01)

Enhancement of Antigen Presentation by Deletion of Viral Immune Evasion Genes Prevents Lethal Cytomegalovirus Disease in Minor Histocompatibility Antigen-Mismatched Hematopoietic Cell Transplantation
by: Emin Gezinir, et al.
Published: (2020-06-01)

Immunodominant Cytomegalovirus Epitopes Suppress Subdominant Epitopes in the Generation of High-Avidity CD8 T Cells
by: Kirsten Freitag, et al.
Published: (2021-07-01)

Evaluation of T-activated proteins as recall antigens to monitor Epstein–Barr virus and human cytomegalovirus-specific T cells in a clinical trial setting
by: Nina Körber, et al.
Published: (2020-06-01)

Human Cytomegalovirus Host Interactions: EGFR and Host Cell Signaling Is a Point of Convergence Between Viral Infection and Functional Changes in Infected Cells
by: Byeong-Jae Lee, et al.
Published: (2021-05-01)

Increased infiltration and tolerised antigen-specific CD8+ TEM cells in tumor but not peripheral blood have no impact on survival of HCMV+ glioblastoma patients
by: M. Bahador, et al.
Published: (2017-08-01)

Immunomonitoring of Human Breast Milk Cells During HCMV-Reactivation
by: Katrin Lazar, et al.
Published: (2021-09-01)

Differences in Growth Properties among Two Human Cytomegalovirus Glycoprotein O Genotypes
by: Julia Kalser, et al.
Published: (2017-08-01)

Localization of Viral Epitope-Specific CD8 T Cells during Cytomegalovirus Latency in the Lungs and Recruitment to Lung Parenchyma by Airway Challenge Infection
by: Franziska Blaum, et al.
Published: (2021-09-01)

Priming of NK cell anti-viral effector mechanisms by direct recognition of Human Cytomegalovirus
by: Aura eMuntasell, et al.
Published: (2013-02-01)

The CD4+ T Cell Response to Human Cytomegalovirus in Healthy and Immunocompromised People
by: Eleanor Y. Lim, et al.
Published: (2020-05-01)

A diverse repertoire of CD4 T cells targets the immediate-early 1 protein of human cytomegalovirus
by: Stefanie eAmeres, et al.
Published: (2015-11-01)

Mouse Model of Cytomegalovirus Disease and Immunotherapy in the Immunocompromised Host: Predictions for Medical Translation that Survived the “Test of Time”
by: Matthias J. Reddehase, et al.
Published: (2018-12-01)

Positive Role of the MHC Class-I Antigen Presentation Regulator m04/gp34 of Murine Cytomegalovirus in Antiviral Protection by CD8 T Cells
by: Sara Becker, et al.
Published: (2020-08-01)

Cytomegalovirus-Associated Inhibition of Hematopoiesis Is Preventable by Cytoimmunotherapy With Antiviral CD8 T Cells
by: Angelique Renzaho, et al.
Published: (2020-04-01)

Production Strategies for Pentamer-Positive Subviral Dense Bodies as a Safe Human Cytomegalovirus Vaccine
by: Patricia Gogesch, et al.
Published: (2019-09-01)

Promising Cytomegalovirus-Based Vaccine Vector Induces Robust CD8<sup>+</sup> T-Cell Response
by: Jian Liu, et al.
Published: (2019-09-01)

The Anti-apoptotic Murine Cytomegalovirus Protein vMIA-m38.5 Induces Mast Cell Degranulation
by: Julia K. Schmiedeke, et al.
Published: (2020-08-01)

HCMV infections after hematopoietic stem cell transplantation – diagnostic methods and importance of viral DNA level monitoring
by: Joanna Bocian, et al.
Published: (2015-02-01)

Mouse Cytomegalovirus Differentially Exploits Cell Surface Glycosaminoglycans in a Cell Type-Dependent and MCK-2-Independent Manner
by: Sergio M Pontejo, et al.
Published: (2019-12-01)

Joint Cell Activation and Selection for Green Communications in Ultra-Dense Heterogeneous Networks
by: Tianqing Zhou, et al.
Published: (2018-01-01)

Impact of HCMV infection on NK cell development and function after HSCT
by: Mariella eDella Chiesa, et al.
Published: (2013-12-01)

Pre-Symptomatic Human Cytomegalovirus Disease Diagnosis in Renal Transplant Recipients by the Virus DNA PCR
by: S Amini-Bavil-Olyaee, et al.
Published: (2005-08-01)